Aptatek Biosciences
Princeton
About Aptatek Biosciences
Aptatek develops the diagnosis and monitoring of inborn diseases in centralized laboratories. Aptatek’s core technology is based on DNA aptamer sequences that detect small-molecule biomarkers and blood pressure. They can identify a large range of markers that are now only analyzed in a laboratory.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $4.0M
- Funding stage: Seed
- Last round: Debt Financing (Jun 2025)
- Website: aptatek.com
- Phone: [email protected]
Industries & Categories
Compliance, Health Care, Information Technology, Medical Device, Wellness
Social Profiles
Canonical: https://fsome.com/organization/aptatek-biosciences-4934 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.